On multivariable analyses that adjusted for the effects of standard clinicopathological variables, N-cadherin expression was not associated anymore with probabilities of recurrence (p = 0.6), overall mortality (p = 0.2) or cancer-specific mortality (p = 0.9). The gene discussed is CDH2; the disease is cancer.